Comment on "Development of eruptive pseudoangiomatosis following COVID-19 inmunization-apropos of 5 cases": could eruptive pseudoangiomatosis represent a paraviral eruption associated with SARS-CoV-2?


Posted: 2021-10-17 19:00:00
J Eur Acad Dermatol Venereol . 2021 Oct 17. doi: 10.1111/jdv.17750. Online ahead of print. Affiliations Expand Affiliations 1 Dermatology Department, Hospital Universitario Fundación Jimenez Diaz, Madrid, Spain. 2 Dermatology Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain. 3 Pathology Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain. Item in Clipboard Cristina Moya-Martinez et al. J Eur Acad Dermatol Venereol. 2021. Show details Display options Display options Format J Eur Acad Dermatol Venereol . 2021 Oct 17. doi: 10.1111/jdv.17750. Online ahead of print. Affiliations 1 Dermatology Department, Hospital Universitario Fundación Jimenez Diaz, Madrid, Spain. 2 Dermatology Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain. 3 Pathology Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain. Item in Clipboard CiteDisplay options Display options Format Abstract We read with great interest the recently published letter on your journal "Development of eruptive pseudoangiomatosis following COVID-19 immunization- apropos of 5 cases",1 as we have just seen a case of this entity related to COVID-19 vaccine in our hospital. Keywords: COVID-19; COVID-19 vaccination; SARS-CoV-2; eruptive pseudoangiomatosis; paraviral eruptions. This article is protected by copyright. All rights reserved. Publication types [x] Cite Copy Format: Send To [x]

参考サイト PubMed: covid-19


Powered by Kreditvergleich


バイオクイックニュース日本語版:COVID-19特集

ゲスト 525人 と メンバー 6人 がオンラインです